4.3 Article

Reproducibility of MDM2 and CDK4 staining in soft tissue tumors

Journal

AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume 125, Issue 5, Pages 693-697

Publisher

AMER SOC CLINICAL PATHOLOGY
DOI: 10.1309/VMBP67QUNN6Q3J0E

Keywords

MDM2; CDK4; immunohistochemistry; reproducibility; sarcoma; tissue microarray

Categories

Ask authors/readers for more resources

MDM2 and CDK4 immunostaining can be useful adjuncts in diagnosing liposarcoma among soft tissue neoplasms. We examined the reproducibility of MDM2 cued CDK4 staining between. 2 laboratories and between tissue microarrays and whole tissue sections. Sixty-two soft tissue tumors were immunostained at the Bergonie Institute, Bordeaux, France, and the Curie Institute, Paris, France. We also examined 203 soft tissue neoplasms on standard tissue sections and tissue microarrays. There was high concordance of results obtained from. the 2 laboratories (with 2 different pathologists) for MDM2 (kappa, 0.93) and CDK4 (kappa, 0.8) staining. There also was excellent concordance between results on tissue microarray and on whole tissue sections for MDM2 (kappa, 0.80) and CDK4 (kappa, 0.93). Immunostaining for MDM2 and CDK4 is a reproducible technique that may be exported to different laboratories for routine use. Tissue microarray is indicated, for studying large series.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available